These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20154470)

  • 1. Establishment of a concept of visceral fat syndrome and discovery of adiponectin.
    Matsuzawa Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2010; 86(2):131-41. PubMed ID: 20154470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin: a key player in obesity related disorders.
    Matsuzawa Y
    Curr Pharm Des; 2010 Jun; 16(17):1896-901. PubMed ID: 20370675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fat topology in the risk of disease.
    Matsuzawa Y
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S83-92. PubMed ID: 19136997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological significance of adiponectin.
    Nishida M; Funahashi T; Shimomura I
    Med Mol Morphol; 2007 Jun; 40(2):55-67. PubMed ID: 17572841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk of adipokines: a review.
    Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC
    J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism.
    Matsuzawa Y; Funahashi T; Nakamura T
    J Atheroscler Thromb; 2011; 18(8):629-39. PubMed ID: 21737960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic syndrome and visceral fat in women with cardiovascular risk factor].
    Soto Rodríguez A; García Soidán JL; Arias Gómez MJ; Leirós Rodríguez R; Del Álamo Alonso A; Pérez Fernández MR
    Nutr Hosp; 2017 Jul; 34(4):863-868. PubMed ID: 29095010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity.
    Kantartzis K; Rittig K; Balletshofer B; Machann J; Schick F; Porubska K; Fritsche A; Häring HU; Stefan N
    Clin Chem; 2006 Oct; 52(10):1934-42. PubMed ID: 16916991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions.
    Lopez-Jaramillo P
    J Nutr; 2016 Feb; 146(2):422S-426S. PubMed ID: 26764331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome and adipocytokines.
    Matsuzawa Y
    FEBS Lett; 2006 May; 580(12):2917-21. PubMed ID: 16674947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of adipocytokines in obesity-related diseases.
    Matsuzawa Y; Shimomura I; Kihara S; Funahashi T
    Horm Res; 2003; 60 Suppl 3():56-9. PubMed ID: 14671398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia: a common basis for diseases associated with overnutrition.
    Funahashi T; Matsuzawa Y
    Curr Atheroscler Rep; 2006 Sep; 8(5):433-8. PubMed ID: 16901415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation: a study in pre-diabetic Japanese middle-aged men.
    Mori Y; Hoshino K; Yokota K; Itoh Y; Tajima N
    Endocrine; 2006 Feb; 29(1):149-53. PubMed ID: 16622304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The link between abdominal obesity and the metabolic syndrome.
    Phillips LK; Prins JB
    Curr Hypertens Rep; 2008 Apr; 10(2):156-64. PubMed ID: 18474184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease.
    Schrover IM; van der Graaf Y; Spiering W; Visseren FL;
    Eur J Prev Cardiol; 2018 Sep; 25(14):1548-1557. PubMed ID: 30052066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Different adipose tissue depots and metabolic syndrome in human].
    Wang R; Li XN
    Sheng Li Xue Bao; 2017 Jun; 69(3):357-365. PubMed ID: 28638930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White adipose tissue and cardiovascular disease.
    Matsuzawa Y
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):637-47. PubMed ID: 16311222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets.
    Iannucci CV; Capoccia D; Calabria M; Leonetti F
    Curr Pharm Des; 2007; 13(21):2148-68. PubMed ID: 17627547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus.
    Saito T; Murata M; Otani T; Tamemoto H; Kawakami M; Ishikawa SE
    Endocr J; 2012; 59(1):39-45. PubMed ID: 22019947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
    Mangge H; Zelzer S; Puerstner P; Schnedl WJ; Reeves G; Postolache TT; Weghuber D
    Obesity (Silver Spring); 2013 Jan; 21(1):E71-7. PubMed ID: 23401248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.